Deal Ticker: BC Platforms AG closes million Series C Financing and enters into partnership with IQVIA

BC Platforms AG closes $15 million Series C Financing and enters into commercial collaboration with IQVIA

The round was led by IQVIA (NYSE: IQV) in conjunction with other investors comprising Debiopharm Innovation Fund and Tesi, a Finnish venture capital and private equity company. Further to the investment round, IQVIA and BCP entered into a commercial collaboration which is intended to launch new data driven technologies, integrating complex clinical and genomic data.

IQVIA is a leading global provider of advanced analytics, technology solutions and contract research services to the life sciences industry dedicated to delivering actionable insights. IQVIA has approximately 65,000 employees worldwide. BCP is a Swiss company with various entities around the world acting in genomic data management and analytics. Through the envisaged collaboration, IQVIA and BC Platforms plan to build a world leading analytics platform to enable the pharmaceutical industry's advancement of precision medicine.

Kellerhals Carrard acted as lead legal advisor to IQVIA on this transaction. The team of Kellerhals Carrard comprised Nicolas Mosimann (Lead), Marco Sibold, Sophie Holdt, Larissa Simeon and Thomas Nösberger (all Corporate/M&A), Laura Manz and Nina Studer (both Commercial) Melanie Huber (Employment) and Daniel Emch and Stefanie Schuler (both Anti-trust). Read more